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Abstract
Meningococcal disease (MCD) is the leading infectious cause of death in early childhood in the United Kingdom, making it a
public health priority. MCD most commonly presents as meningococcal meningitis (MM), septicaemia (MS), or as a
combination of the two syndromes (MM/MS). We describe the changing epidemiology and clinical presentation of MCD,
and explore associations with socioeconomic status and other risk factors. A hospital-based study of children admitted to a
tertiary children’s centre, Alder Hey Children’s Foundation Trust, with MCD, was undertaken between 1977 to 2007
(n = 1157). Demographics, clinical presentations, microbiological confirmation and measures of deprivation were described.
The majority of cases occurred in the 1–4 year age group and there was a dramatic fall in serogroup C cases observed with
the introduction of the meningococcal C conjugate (MCC) vaccine. The proportion of MS cases increased over the study
period, from 11% in the first quarter to 35% in the final quarter. Presentation with MS (compared to MM) and serogroup C
disease (compared to serogroup B) were demonstrated to be independent risk factors for mortality, with odds ratios of 3.5
(95% CI 1.18 to 10.08) and 2.18 (95% CI 1.26 to 3.80) respectively. Cases admitted to Alder Hey were from a relatively more
deprived population (mean Townsend score 1.25, 95% CI 1.09 to 1.41) than the Merseyside reference population. Our
findings represent one of the largest single-centre studies of MCD. The presentation of MS is confirmed to be a risk factor of
mortality from MCD. Our study supports the association between social deprivation and MCD.
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Introduction
Meningococcal disease (MCD) is seen predominantly in infancy
and early childhood, with a higher incidence in males [1]. As early
as 1919, Rolleston [2] stated that "half the total cases occur in first
five years of life", a statement that still applies today [3]. A
significant change in age distribution was first observed in 1995,
with a higher proportion of cases in older children and adults.
There is now a second definite peak occurring in teenage years.
The case fatality rates are high in under fives, low in school age
children, and highest in those aged 25 years or more [4,5].
In the United Kingdom, case fatality rates have been falling
steadily since 1985, a trend which has been attributed to more
efficient ascertainment of milder surviving cases [4], improvements
in clinical management [6,7], and the introduction of the
meningococcal C conjugate vaccine [8]. The overall European
picture has been similar to that in the United Kingdom, with
overall case-fatality rates falling and the incidence of serogroup C
disease also falling [9,10,11].
The association between incidence of MCD and socio-
economic status is well described, with a relative risk of
approximately two when comparing extremes of deprivation
quintiles [12,13,14]. Mortality rates from MCD are also associated
with social deprivation, with rates being increased in the most
deprived children [12,15].
The aims of the study were to describe the epidemiology of
MCD in admissions to a single tertiary children’s hospital on
Merseyside, England over a 31 year period and to determine if
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there was any evidence of an association between MCD and
socioeconomic variables within a well-defined geographic region.
Methods
The data were collected prospectively (n=692), (1988–1990,
1992–1994, 1997–1999, 2000–2002 , 2004–2006 and 2007–2009)
and retrospectively (n=465), in children admitted to Alder Hey
Children’s NHS Foundation Trust (formerly Royal Liverpool
Children’s Hospital) and Myrtle Street Hospital (until its closure in
1989). During the periods when the data were collected prospectively,
a dedicated clinical research fellow was contacted each time a child
with suspected MCD was admitted either to the emergency
department or the intensive care unit. Detailed clinical, demographic,
microbiology and laboratory data were collected on all children
admitted prospectively. For cases collected retrospectively, a
combination of hospital records, hospital electronic information
system data and microbiology results from the Health Protection
Agency (formerly Public Health Laboratory Service) were used.
Children were included in the database if they had microbio-
logical confirmation or a probable diagnosis of MCD. Microbi-
ological confirmation was defined as: positive cultures, positive
polymerase chain reaction (PCR) for meningococcal DNA,
detection of Gram-negative diplococci in CSF, or detection of
meningococcal antigen in blood, CSF or synovial fluid; or
abnormal CSF parameters (pleocytsis, low glucose, high protein)
with positive serology for meningococcal infection; or positive
throat swab in an ill child with fever and a petechial or purpuric
rash. A probable diagnosis was made in children with negative
microbiology, and who were either admitted to PICU (Paediatric
Intensive Care Unit) with septicaemic shock and a purpuric/
haemorrhagic rash, or who had post mortem findings consistent
with a diagnosis of fulminant MCD [16].
The dataset contained information on date of admission,
postcode of residence, gender, age, diagnosis (Meningococcal
septicaemia alone (MS), Meningococcal Meningitis alone (MM) or
a mixed picture (MM/MS)), Serogroup (B, C or Other), whether
or not the patient survived and Glasgow Meningococcal
Septicaemia Prognostic Score (GMSPS). Postcodes were used to
generate the Townsend Score, a measure of social deprivation for
the home address of each patient [17]. Using the online tool
GeoConvert http://geoconvert.mimas.ac.uk/, we used the pa-
tient’s postcodes to obtain coordinates for each of their residences,
and to calculate their distance from the admitting hospital, Alder
Hey Children’s NHS Foundation Trust.
The Townsend score [17] is an area level measure of material
deprivation, based on four indicators which are measured during
the national census (i.e. the percentage of economically active
residents who are unemployed, the percentage of private
households who do not possess a car, the percentage of private
households not owner occupied, and the percentage of private
households with more than one person per room in a particular
area). As it is a standardised score, a reference population needs to
be selected. Using data from the 1981, 1991 and 2001 censuses,
the four indicators were obtained for each census area within
which patients admitted to Alder Hey Children’s NHS Foundation
Trust with meningococcal disease resided. The Townsend scores
for each small area were then calculated, using Merseyside as the
reference population. The patient was then assigned the Town-
send score of their area of residence, for their decade of admission.
For example, if a patient was admitted in 1994, they were assigned
the Townsend score calculated for their area of residence using the
1991 census data. There were four missing Townsend scores, due
to missing postcode information. There were 610 (52.7%) missing
GMSPS scores, with the majority of missing scores occurring pre-
1988, 1995–1997, and 2002–2004.
For the purpose of tabulating the data, four admission year
groups were defined as 1977–1984, 1985–1992, 1993–2000 and
2001–2007. The third admission year group is the period of time
in which a great increase in MCD cases was observed nationally,
resulting in the introduction of the Meningococcal C vaccine in
November 1999. Age groups were chosen in accordance with
those used by the Health Protection Agency (Under 1 year, 1–4
years, 5–9 years, 10–14 years, over 15 years) [18].
The analysis was undertaken using R version 2.10.1 (www.r-
project.org). Logistic regression modelling was used to assess the
effect of covariates on risk of death. A backwards stepwise
procedure was used for model selection.
Ethical approval was granted by Local Research Ethics
Committee. Each prospective study was formally approved by
the Local Research Ethics Committee at the time. Written consent
was supplied by the parent/guardian of the patient using
standardised consent forms for the institution, and gives consent
for data collected during the study to be accessed and analysed by
individuals for the purposes of research.
This is a single centre study run out of what was originally the
Royal Liverpool Children’s NHS Hospital. In 2009, the Trust
received Foundation Trust status and the name changed to Alder
Hey Children’s NHS Foundation Trust. This is a purely
administrative change in name. The protocol required review by
one ethics committee at this institution. This protocol has received
Institutional Review Board consideration throughout the duration
of the study life. The hospital as an organization is the same and all
ethical considerations have been complied with via the hospital’s
research review policies and standard operating procedures.
Results
A total of 1157 patients were admitted to Alder Hey Children’s
NHS Foundation Trust with MCD during the 31 year period from
1977–2007 inclusive. The age range of patients admitted to Alder
Hey was 0–16 years inclusive, although the dataset only contains
one patient aged 16. Of the 1157 admissions, 43.5% were female
and 56.5% were male.
Figure 1 illustrates the geographical spread of postcode of
residents of patients in the dataset. The majority of these are from
the Merseyside area (864 patients – 74.7%), with some patients
being resident in other areas of England and Wales, who were
transferred in from other hospitals for intensive care management.
The histograms in Figure 2 show the numbers of cases admitted to
Alder Hey by period of admission, stratified by serogroup, age,
disease type and outcome. Overall, there is a stepwise rise in cases
between 1985–1992 and 1993–2000, after which the number of
cases declines, following the introduction of the meningococcal C
vaccine in 1999.
Throughout the study period, serogroup B has been the most
common serogroup (64.4% overall) (Table 1). The percentage of
serogroup C cases increased greatly during the middle two
admission periods, and decreased significantly during the final
admission period (Figure 2a) to the extent that no serogroup C
cases occur after 2003.
The majority of cases in each admission period were aged 4 and
under (80% overall) (Table 2). There appears to have been a
reduction in the proportion of cases in this age group between the
first two time periods from 87.6% (374/427) to 74.1% (541/730)
in the last two time periods. In contrast, there is an increase in the
proportion of cases in the 10–14 age group between the first two
time periods (13/427) and the last two time periods (69/730)
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(Table 2, Figure 2b). The differences between each of these pairs
of proportions are statistically significant, with p-values less than
0.0001. However, in terms of absolute numbers, in comparing the
periods 1985–1992 and 2001–2007 it was noted that there was no
real reduction in the absolute number of cases under 4, with the
number of cases being 226 and 218 respectively.
Density plots of the Townsend score for both the reference
population of Merseyside by census year (1981, 1991 and 2001)
and the cases (Figure 3) show that in general, the Townsend score
of the cases is larger than that of the reference population. The
mean Townsend score for the cases was 1.25, with a 95%
confidence interval of (1.09, 1.41).
Figure 1. Location of MCD cases admitted to Alder Hey 1977–2007. Maps are of the UK, and of Merseyside only. The location of Alder Hey is
clearly highlighted.
doi:10.1371/journal.pone.0025957.g001
Table 1. Alder Hey meningococcal disease cases by serogroup, age group and admission year group.
Admission Year
Age group Serotype 1977–84 1985–92 1993–2000 2001–07 Total
Under 1 B 52 (78.79%) 74 (71.15%) 71 (55.47%) 80 (80.81%) 277 (69.77%)
C 5 (7.58%) 22 (21.15%) 38 (29.69%) 5 (5.05%) 70 (17.63%)
OTHER 9 (13.64%) 8 (7.69%) 19 (14.84%) 14 (14.14%) 50 (12.59%)
1–4 B 56 (68.29%) 86 (70.49%) 93 (45.37%) 102 (85.71%) 337 (63.83%)
C 7 (8.54%) 29 (23.77%) 85 (41.46%) 2 (1.68%) 123 (23.30%)
OTHER 19 (23.17%) 7 (5.74%) 27 (13.17%) 15 (12.61%) 68 (12.88%)
5–9 B 10 (83.33%) 12 (44.44%) 30 (49.18%) 26 (83.87%) 78 (59.54%)
C 1 (8.33%) 11 (40.74%) 18 (29.51%) 2 (6.45%) 32 (24.43%)
OTHER 1 (8.33%) 4 (14.81%) 13 (21.31%) 3 (9.68%) 21 (16.03%)
10–14 B 4 (80.00%) 4 (50.00%) 16 (37.21%) 20 (76.92%) 44 (53.66%)
C 0 (0.00%) 4 (50.00%) 18 (41.86%) 3 (11.54%) 25 (30.49%)
OTHER 1 (20.00%) 0 (0.00%) 9 (20.93%) 3 (11.54%) 13 (15.85%)
15+ B 1 (100.00%) 0 (-) 3 (23.08%) 5 (100.00%) 9 (47.37%)
C 0 (0.00%) 0 (-) 8 (61.54%) 0 (0.00%) 8 (42.11%)
OTHER 0 (0.00%) 0 (-) 2 (15.38%) 0 (0.00%) 2 (10.53%)
All ages B 123 (74.10%) 176 (67.43%) 213 (47.33%) 233 (83.21%) 745 (64.39%)
C 13 (7.83%) 66 (25.29%) 167 (37.11%) 12 (4.29%) 258 (22.30%)
OTHER 30 (18.07%) 19 (7.28%) 70 (15.56%) 35 (12.50%) 154 (13.31%)
Total 166 261 450 280 1157
doi:10.1371/journal.pone.0025957.t001
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The disease profile changed over the study period. Clinical
presentation withMS became more common with time, accounting
for 34.6% in the last quarter, compared to 10.8% in the first
(Table 3, Figure 2c). Accordingly, the proportion of cases presenting
with MM reduced, though a mixed picture of MM/MS was
consistently the most common presentation overall (53.7% in total).
Overall the proportion of deaths for the entire study period was
5.5% (63 deaths). The proportion of deaths was highest during the
1985–1992 admission period (9.6%), and subsequently reduced
significantly, such that there were no deaths in the study
population after 2000 (Table 4 and Figure 2d). Overall, the
proportion of deaths was highest in the MS group (7.7%)
compared to the MM/MS group (5.2%) and the MM group
(2.2%) (Table 4). There were statistically significant differences
amongst these proportions (p = 0.0233). Of the patients with
serogroup B disease, 4.4% died (33/745) compared to 9.3% of
children with serogroup C infection (24/258) (p = 0.0058). In
absolute terms, most of the deaths occurred in infants (30.2%) and
the 1–4 years age group (47.6%). The overall proportion of deaths
in infants was 4.8% (19/397), 5.7% in the 1–4 years age group,
3.8% (5/131) in the 5–9 years group, 7.3% (6/82) in the 10–14
years group and 15.8% (3/19) in the over 15 years age group.
Figure 2. Histograms of numbers of cases by year group of admission. Cases are stratified by serogroup (A), age group (B), disease type (C)
and outcome (D).
doi:10.1371/journal.pone.0025957.g002
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Table 5 shows the results of fitting the multiple logistic model to
the data, thereby exploring which factors are associated with risk
of death in patients admitted to Alder Hey. The final model
included disease presentation and serogroup. Adding any or all of
age, sex, Townsend score and distance from Alder Hey gave no
significant improvement in fit over the final model. The risk of
death was higher for patients with MS and infection with
serogroup C disease. The odds ratio (OR) for death was 3.5
(95% CI 1.18 to 10.08) in the MS group, compared to MM. The
OR for death in the serogroup C group, compared to serogroup B
was 2.18 (95% CI 1.26 to 3.80).
Discussion
We undertook a descriptive epidemiological study of 1157
children admitted to Alder Hey Children’s NHS Foundation Trust
with MCD during the 31 year period from 1977–2007. This is the
largest published dataset containing clinical, microbiological and
socioeconomic data of children with MCD from a single region.
Merseyside has a higher incidence of MCD than the rest of the
North West of England, and England and Wales as a whole. Data
from the Health Protection Agency indicate that the incidence of
MCD in England and Wales for 2008 and 2009 was 2.26/100,000
and 1.88/100,000 respectively. By comparison, the figures for the
North West of England and Merseyside respectively were: 2008:
2.39 and 2.79/100,000 and 2009: 2.35 and 3.63/100,000.
There was a dramatic increase in the number of cases between
1995 and 1998, after which the number declined, following the
introduction of the meningococcal C vaccine. The success of the
meningococcal C vaccine is evident in the fact that there are no
serogroup C cases after 2003, despite a significant rise in the
proportion of serogoup C cases in the period preceding this. In
terms of demographic characteristics, we observed a slight male
bias in presentations from the Merseyside area. The cases appear
to be drawn from a relatively more deprived population than the
Merseyside reference population. A total of 80% of cases were in
the 1–4 year age group, but over the data collection period there is
a relative increase in the proportion of cases in older age groups.
Molecular diagnosis for detection of meningococcal DNA was
introduced in 1996. As a result, ascertainment increased [19,20],
and this increased ascertainment most likely explains the
observation that absolute numbers of under 4yr olds has been
fairly constant between the periods 1985–1992 and 2001–2007.
Specifically, with a relative decrease in the proportion of cases in
this age group, and fewer cases overall, one would expect a
decrease in absolute numbers. However increased case ascertain-
ment with meningococcal PCR is the most likely explanation for
why this is not observed.
Presentation with a mixed picture of MM/MS was consistently
the most common clinical presentation overall, though MS
became a relatively more common presentation over the data
collection period, rising from 11% to 35%. This increase in
proportion of cases with MS is likely to be due to less lumbar
punctures being performed, and in particular the recommendation
that lumbar puncture is not performed in children with a purpuric
rash. Hence, cases that would have previously been ascribed to
MM/MS following a lumbar puncture are now more likely to be
ascribed to MS. The low fatality rate despite higher proportions of
septicaemia in the last study period (0/97) is in all likelihood due to
improved mortality as a result of prompt recognition and
aggressive management of the disease [6,7]. Mortality was greatest
during the 1985–1992 admission period (9.6%), but subsequently
there was a significant reduction. There were no deaths between
2001 and 2007. This significant reduction in mortality from MCD
has been attributed to earlier recognition of disease, and more
aggressive management of cases on admission to hospital and in
intensive care [6,7].
MS (compared to MM) and serogroup C (compared to
serogroup B) emerged as independent risk factors for mortality.
MS is the most fulminant disease presentation of MCD as it can
rapidly progress to septic shock, multi-organ failure and death.
Prompt recognition and early aggressive management of the
critically ill child has led to significant improvements in outcome in
children with meningococcal septic shock [21]. Social deprivation
and distance from hospital were not significant risk factors for
MCD mortality in our analysis.
Table 2. Alder Hey meningococcal disease cases by age group and admission year group.
Admission Year
Age Group 1977–84 1985–92 1993–2000 2001–07 Total
Under 1 66 (39.76%) 104 (39.85%) 128 (28.44%) 99 (35.36%) 397 (34.31%)
1–4 82 (49.40%) 122 (46.74%) 205 (45.56%) 119 (42.50%) 528 (45.64%)
5–9 12 (7.23%) 27 (10.34%) 61 (13.56%) 31 (11.07%) 131 (11.32%)
10–14 5 (3.01%) 8 (3.07%) 43 (9.56%) 26 (9.29%) 82 (7.09%)
15+ 1 (0.60%) 0 (0.00%) 13 (2.89%) 5 (1.79%) 19 (1.64%)
Total 166 261 450 280 1157
doi:10.1371/journal.pone.0025957.t002
Figure 3. Smoothed density plot of Townsend scores for the
reference population of Merseyside and MCD cases. The
reference population is plotted for 1981 (dashed line), 1991 (dotted
line), 2001 (dashed-dotted line). Townsend scores for the cases are
represented by a solid line.
doi:10.1371/journal.pone.0025957.g003
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By examining this unique dataset, containing data which has
been collected over a 31 year period from 1977-2007, we have been
able to describe a range of socio-demographic and clinical
characteristics, and explore risk factors for mortality. The strengths
of the study are the large dataset from a single centre, the fact that
most of the data was collected prospectively by a dedicated clinical
research fellow, and that data on clinical presentation in addition to
microbiology and postcode were collected. Weaknesses of this study
include the fact that the analysis is linked to a single centre, for
which it is not possible to define a discrete catchment population.
Thus we were unable to undertake an area-based study of incidence
of MCD and were limited to a largely descriptive analysis. Further,
there is potential for ascertainment bias with respect to information
on patient mortality as the mortality data only takes into account
children who reach this tertiary centre. In exploring the effect of
deprivation, we used the population of Merseyside as the reference
population, and generated Townsend scores for successive time
periods. It was not possible to use more current deprivation
measures such as Index of Multiple Deprivation [22], as this was
only available from 2000 onwards. We were limited to cross-
sectional analysis by deprivation, since the Townsend score is a
relative measure, and cannot be used as an absolute measure of
deprivation to identify absolute change over time. We have used a
small-area-based measure of deprivation, since we did not have
access to individual-level measures of socio-economic status, and
any associations are thus ecological [23].
In our analysis we found that the cases admitted to Alder Hey
were from a relatively more deprived population than the
Merseyside reference population, but that deprivation score was
not a risk factor for mortality. This is in line with other studies in
Wales and the Eastern region of England that have shown an
association between MCD and social deprivation at an area level
[13,14]. Unlike our study, Heyderman et al. [12] have suggested a
link between social deprivation and meningococcal mortality,
possibly mediated by factors such as overcrowding, damp living
conditions, environmental tobacco smoke exposure and viral
upper respiratory tract infections, which may lead to increased
exposure and/or carriage of Neisseria meningitidis or impaired
host defences against bacterial invasion.
Olowokure et al. [24] demonstrate an interaction between
urban/rural indicators and social deprivation, with the most
deprived community in the urban areas being twice as likely as the
most deprived community in the rural area to have MCD. In our
study, most cases were classified as living in urban areas, therefore
we were not able to demonstrate an association with rural or
urban residence. However, distance from hospital did not have a
significant effect on risk of mortality from MCD.
In conclusion, our large dataset demonstrates that most cases
occur in the first five years of life, and confirms MS and serogroup
C disease as independent risk factors for mortality. Additionally,
the cases admitted to Alder Hey were from a relatively more
deprived population than the Merseyside reference population,
but deprivation score was not a risk factor for mortality.
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Diagnosis: MS -0.2853 3.4537 (1.183001, 10.082928) 0.02
Serogroup: C 0.8685 2.1867 (1.258814, 3.798563) 0.01
Serogroup: Other 1.2394 0.7518 (0.287441, 1.966337) 0.56
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